Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Platelet-activating factor acetylhydrolase (PAF-AH) therapeutic uses

Platelet-activating factor acetylhydrolase (PAF-AH) therapeutic uses

US Patent 6099836 · Granted Aug 8, 2000

Estimated economic value: $23,108,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods for inhibiting angiogenesis in a subject in need thereof2024
Antibodies specifically binding to MASP-3 for the treatment of various diseases 2024
Methods of generating bioactive peptide-bearing antibodies and compositions comp2021
Methods of generating bioactive peptide-bearing antibodies and compositions comp2021
Antibodies specifically binding to MASP-3 for the treatment of various diseases 2021
Methods for inhibiting angiogenesis in a subject in need thereof2020
Nucleic acids encoding antibodies specifically binding to MASP-32020
Antibodies specifically binding to MASP-3 for the treatment of various diseases 2020
Anti-FZD10 monoclonal antibodies and methods for their use2017
Composition and method for diversification of target sequences2017
Generation of anti-FN14 monoclonal antibodies by ex-vivo accelerated antibody ev2016
Use of PDE7 inhibitors for the treatment of movement disorders2015